TweetA research team from the University at Texas San Antonio was recently granted a U.S. patent for a method to diagnose the presence of Francisella tularensis, the bacteria that causes the disease tularemia. While tularemia remains a rarely occurring natural … Read More

DiaMedica announced this week that it has entered into an evaluation agreement with the National Institute of Allergy and Infectious Diseases to further examine its monoclonal antibody for the treatment of the potential bioweapon tularemia. Read More

An outbreak of tularemia, a bacterial zoonosis caused by Francisella tularensis, which is one of the most pathogenic bacteria known, has been reported in Norway, causing 39 cases from January through March. Read More

The Defense Threat Reduction Agency has awarded Aduro BioTech, a clinical-stage immunotherapy company, with the Read More

A disease that is normally found in rodents and rabbits has raised enough concern over its potential use as a bioterrorist threat that health officials are kicking off a study to examine potential vaccines. Read More